Moody Lynn & Lieberson LLC Grows Position in iShares Biotechnology ETF $IBB

Moody Lynn & Lieberson LLC increased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 192.9% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 15,831 shares of the financial services provider’s stock after buying an additional 10,426 shares during the quarter. Moody Lynn & Lieberson LLC’s holdings in iShares Biotechnology ETF were worth $2,672,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF in the second quarter worth approximately $25,000. Ashton Thomas Securities LLC purchased a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $36,000. Parkside Financial Bank & Trust lifted its position in iShares Biotechnology ETF by 48.6% during the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 87 shares during the period. Close Asset Management Ltd lifted its position in iShares Biotechnology ETF by 25.5% during the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after purchasing an additional 70 shares during the period. Finally, Founders Financial Alliance LLC boosted its holdings in iShares Biotechnology ETF by 605.7% in the third quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after purchasing an additional 321 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 4.3%

NASDAQ:IBB opened at $168.85 on Wednesday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $179.64. The company has a 50 day simple moving average of $170.97 and a two-hundred day simple moving average of $164.70.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.